Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
20172018
January
February
March
April
May
June
July
August
September
October
November
December
2019

2018

-

April

Date
Title
Category
Company
April 3, 2018
HPV program: Perfect Use of Our Health Goldmine
Life Science
Oslo Cancer Cluster
April 3, 2018
AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T) for Third-Line Treatment of Patients with DLL3-Expressing Relapsed/Refractory Small Cell Lung Cancer
Medtech
AbbVie
April 4, 2018
AbbVie is Now Accepting CF Scholarship Applications from Students with Cystic Fibrosis for 2018-2019 Academic School Year
Pharma
AbbVie
April 4, 2018
InDex Pharmaceuticals gets new patent in Japan
Pharma
InDex Pharmaceuticals
April 4, 2018
It started as a skin cream and is now fighting common colds everywhere – meet Enzymatica
Life Science
Ideon Science Park
April 4, 2018
Where are the most active European biotech venture capital firms located?
Life Science
Medicon Valley Alliance
April 4, 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba® label
Pharma
Novo Nordisk Pharmatech A/S
April 4, 2018
Save the date: InDex Pharmaceuticals to host Capital Markets Day in Stockholm on April 25, 2018
Life Science
InDex Pharmaceuticals
April 4, 2018
SPOTLIGHT ON SWEDEN AND MEDICON VALLEY IN “NATURE”, THE INTERNATIONAL JOURNAL OF SCIENCE
Life Science
Medicon Valley Alliance
April 5, 2018
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis
Pharma
AbbVie
April 9, 2018
How can we use technology developed for space to develop smart cities here on earth?
Life Science
Ideon Science Park
April 9, 2018
A passion for nature and sports brought the creators of Suntribe together
Life Science
Ideon Science Park
April 9, 2018
AbbVie to Host First-Quarter 2018 Earnings Conference Call
Pharma
AbbVie
April 9, 2018
LightningChart® v.8.3 released
Medtech
Arction Ltd
April 9, 2018
DON´T MISS “LIFE SCIENCE VÄXER ÖVER SUNDET” IN SWEDISH “NATURVETAREN”
Life Science
Medicon Valley Alliance
April 12, 2018
AbbVie and Neurocrine Biosciences Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain
Pharma
AbbVie
April 12, 2018
AgVital wants to create a support for a healthier lifestyle
Life Science
Ideon Science Park
April 12, 2018
Ulf G Andersson, CEO of Medeon Science Park & Incubator, Malmö elected new vice-chairman of Medicon Valley Alliance
Life Science
Medicon Valley Alliance
April 26, 2018
Receives Prestigious Grant for a Second Time
Life Science
Oslo Cancer Cluster
April 26, 2018
InDex Pharmaceuticals announces the agenda for its Capital Markets Day in Stockholm on April 25, 2018
Pharma
InDex Pharmaceuticals
April 26, 2018
AbbVie to Present at the Deutsche Bank's 43rd Annual Health Care Conference
Pharma
AbbVie
April 26, 2018
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)
Pharma
InDex Pharmaceuticals
April 26, 2018
Annual General Meeting 2018
Pharma
InDex Pharmaceuticals
April 26, 2018
InDex Pharmaceuticals Holding AB – Annual Report 2017
Finance
InDex Pharmaceuticals
April 26, 2018
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2017
Finance
InDex Pharmaceuticals
April 26, 2018
Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade
Biotech
Cobra Biologics
April 26, 2018
MEDICON VALLEY HAS THE HIGHEST CONCENTRATION OF BIOTECH COMPANIES IN NORTHERN EUROPE (NORTH OF LONDON)
Life Science
Medicon Valley Alliance
April 26, 2018
AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis
Pharma
AbbVie
April 26, 2018
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study in Japanese Patients
Pharma
AbbVie
April 26, 2018
How public private partnerships can help us reach the 17 sustainable development goals for the world
Life Science
Ideon Science Park
April 26, 2018
Spago Nanomedical participates in EU NANO2ALL project
Medtech
Spago Nanomedical
April 26, 2018
Arne Hansson becomes new CEO of Ideon Open
Life Science
Ideon Science Park

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019